Zionexa Revenue and Competitors

Paris, FRA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Zionexa's estimated annual revenue is currently $1.4M per year.(i)
  • Zionexa's estimated revenue per employee is $155,000

Employee Data

  • Zionexa has 9 Employees.(i)
  • Zionexa grew their employee count by 0% last year.

Zionexa's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13M844%N/AN/A
#2
$23.9M154-1%N/AN/A
#3
$44.2M28522%N/AN/A
#4
$24M155-17%N/AN/A
#5
$17.4M1120%$179.5MN/A
#6
$49.4M2391%€201.1MN/A
#7
$54.3M350-3%N/AN/A
#8
$9.3M60N/AN/AN/A
#9
$7.8M50N/AN/AN/A
#10
$20.9M135-16%N/AN/A
Add Company

What Is Zionexa?

Zionexa is an international and innovative company developing and commercializing molecular imaging solutions, in-vivo biomarkers for targeted therapies in oncology, to improve patients' pathway and bring them a better quality of life.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Zionexa News

2022-03-30 - Global Imaging Biomarkers Market (2022 to 2027) - Featuring Siemens, ICON and Median Technologies Among Others - ResearchAndMarkets.com

Siemens Healthineers. ICON Plc. Invicro LLC. Median Technologies. PI Solutions Group GmbH. IXICO plc. Bioxydyn Ltd. Zionexa.

2022-03-30 - Liver Cancer Diagnostics Market Worth $15.95Bn, Globally, by ...

In May 2021, GE Healthcare acquired Zionexa, a France-based in-vivo oncology and neurology biomarker developer, to further develop molecular...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M9-31%N/A
#2
$1.1M9N/AN/A
#3
$0.7M9N/AN/A
#4
$0.7M9N/AN/A
#5
$0.7M9N/AN/A